Drugs / fluticasone propionate/salmeterol
fluticasone propionate/salmeterol
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00864812 | Mar 2009 → Mar 2010 | chronic obstructive pulmonary disease | The Korean Academy of Tuberculosis and Respiratory Diseases | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | fluticasone propionate/salmeterol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00864812 ↗ |
| Known as | fluticasone propionate/salmeterol (FSC): Seretide | “fluticasone propionate/salmeterol (FSC): Seretide” NCT00864812 ↗ |
| Known as | FSC | “tiotropium with fluticasone propionate/salmeterol (FSC)” NCT00864812 ↗ |